About the Project
We recently identified a subset of CD206+ macrophages in prostate tumours that gather around blood vessels and inhibit the proliferation and activation of cytotoxic T cells (CTLs). Our latest data show that these cells express high levels of IL-10 and negative checkpoint regulators like PD-L1, PD-L2, TIM-3 and VISTA. These are known to inhibit various anti-tumour functions of CTLs in tumours.
The PhD student on this project will conduct experiments to see whether CD206-targeted nanoparticles (NPs) containing inhibitors for the above molecules stimulates tumour CTLs and prevent subsequent tumour growth. As we found recently that perivascular CD206+ macrophages are increased prostate tumours after a standard of care treatment for prostate cancer, androgen deprivation therapy (ADT), we will also see whether targeting these cells with NPs, prevents the development of resistance to ADT. The techniques to be used include: cell culture and transfection, immunofluorescence staining of mouse and human tissue sections, FACS, qPCR, synthesis and use of NPs, stats analysis of data, and preclinical models of primary and metastatic prostate tumours.
Candidates must have an upper second class honours degree or equivalent overseas qualification, in a relevant subject.
Interested candidates should in the first instance contact (Professor Claire Lewis, +44 (0)114 215 9012 & email@example.com)
How to apply:
Please complete a University Postgraduate Research Application form available here: www.shef.ac.uk/postgraduate/research/apply
Please clearly state the prospective main supervisor in the respective box and select Oncology and Metabolism as the department.
Based on your current searches we recommend the following search filters.
Based on your current search criteria we thought you might be interested in these.